Bluebird Bio Inc (BLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,321 | -17,240 | -11,127 | -6,544 | -23,670 |
| Depreciation Amortization | 941 | 610 | 304 | 139 | 300 |
| Accounts payable and accrued liabilities | 2,067 | -1,021 | -1,416 | -593 | N/A |
| Other Working Capital | 60,890 | 60,260 | 65,828 | 71,719 | 1,520 |
| Other Operating Activity | 4,873 | 6,296 | 4,176 | 1,297 | 810 |
| Operating Cash Flow | $43,450 | $48,905 | $57,765 | $66,018 | $-21,040 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8,670 | -3,380 | -1,265 | -812 | -860 |
| Other Investing Activity | -1,153 | -1,153 | -1,253 | 0 | 3,450 |
| Investing Cash Flow | $-9,823 | $-4,533 | $-2,518 | $-812 | $2,590 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 105,297 | 105,064 | 106,245 | 34 | N/A |
| Other Financing Activity | 344 | 344 | 344 | -415 | 59,850 |
| Financing Cash Flow | $105,641 | $105,408 | $106,589 | $-381 | $59,850 |
| Beginning Cash Position | 67,011 | 67,011 | 67,011 | 67,011 | 25,600 |
| End Cash Position | 206,279 | 216,791 | 228,847 | 131,836 | 67,010 |
| Net Cash Flow | $139,268 | $149,780 | $161,836 | $64,825 | $41,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 43,450 | 48,905 | 57,765 | 66,018 | -21,040 |
| Capital Expenditure | -8,670 | -3,380 | -1,265 | -812 | N/A |
| Free Cash Flow | 34,780 | 45,525 | 56,500 | 65,206 | -21,040 |